Cargando…
Plasminogen activator inhibitor-2 (PAI-2) overexpression supports bladder cancer development in PAI-1 knockout mice in N-butyl-N- (4-hydroxybutyl)-nitrosamine- induced bladder cancer mouse model
BACKGROUND: Accumulating evidence suggests that plasminogen activator inhibitor-1 (PAI-1) plays an important role in bladder tumorigenesis by regulating cell cycle. However, it remains unclear whether and how inhibition of PAI-1 suppresses bladder tumorigenesis. METHODS: To elucidate the therapeutic...
Autores principales: | Furuya, Hideki, Hayashi, Kazukuni, Shimizu, Yoshiko, Kim, Nari, Tsukikawa, Yutaro, Chen, Runpu, Sun, Yijun, Chan, Owen T. M., Pagano, Ian, Peres, Rafael, Hokutan, Kanani, Igari, Fumie, Chan, Keith S., Rosser, Charles J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7003426/ https://www.ncbi.nlm.nih.gov/pubmed/32024545 http://dx.doi.org/10.1186/s12967-020-02239-6 |
Ejemplares similares
-
Strain Differences in N‐Butyl‐N‐(4‐hydroxybutyl)nitrosamine Bladder Carcinogenesis in Rats
por: Nakanowatari, Jun‐ichi, et al.
Publicado: (1988) -
PAI-1 is a potential transcriptional silencer that supports bladder cancer cell activity
por: Furuya, Hideki, et al.
Publicado: (2022) -
Association of SNPs in the PAI1 Gene with Disease Recurrence and Clinical Outcome in Bladder Cancer
por: Murakami, Kaoru, et al.
Publicado: (2023) -
Effects of promoters on N-butyl-N-(4-hydroxybutyl)nitrosamine-induced urinary bladder carcinogenesis in the rat.
por: Ito, N, et al.
Publicado: (1983) -
Knockout of phospholipase Cε attenuates N-butyl-N-(4-hydroxybutyl) nitrosamine-induced bladder tumorigenesis
por: JIANG, TAIMAO, et al.
Publicado: (2016)